IBDEI10Q ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16375,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,16375,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,16375,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,16376,0)
 ;;=N41.1^^88^876^90
 ;;^UTILITY(U,$J,358.3,16376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16376,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,16376,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,16376,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,16377,0)
 ;;=N11.9^^88^876^98
 ;;^UTILITY(U,$J,358.3,16377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16377,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,16377,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,16377,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,16378,0)
 ;;=N20.9^^88^876^116
 ;;^UTILITY(U,$J,358.3,16378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16378,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,16378,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,16378,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,16379,0)
 ;;=R97.20^^88^876^29
 ;;^UTILITY(U,$J,358.3,16379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16379,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,16379,1,4,0)
 ;;=4^R97.20
 ;;^UTILITY(U,$J,358.3,16379,2)
 ;;=^334262
 ;;^UTILITY(U,$J,358.3,16380,0)
 ;;=N52.36^^88^876^34
 ;;^UTILITY(U,$J,358.3,16380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16380,1,3,0)
 ;;=3^Erectile Dysfunction After Interstitial Seed Therapy
 ;;^UTILITY(U,$J,358.3,16380,1,4,0)
 ;;=4^N52.36
 ;;^UTILITY(U,$J,358.3,16380,2)
 ;;=^5138933
 ;;^UTILITY(U,$J,358.3,16381,0)
 ;;=N52.37^^88^876^35
 ;;^UTILITY(U,$J,358.3,16381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16381,1,3,0)
 ;;=3^Erectile Dysfunction After Prostate Ablative Therapy
 ;;^UTILITY(U,$J,358.3,16381,1,4,0)
 ;;=4^N52.37
 ;;^UTILITY(U,$J,358.3,16381,2)
 ;;=^5138934
 ;;^UTILITY(U,$J,358.3,16382,0)
 ;;=N52.35^^88^876^36
 ;;^UTILITY(U,$J,358.3,16382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16382,1,3,0)
 ;;=3^Erectile Dysfunction After Radiation Therapy
 ;;^UTILITY(U,$J,358.3,16382,1,4,0)
 ;;=4^N52.35
 ;;^UTILITY(U,$J,358.3,16382,2)
 ;;=^5138932
 ;;^UTILITY(U,$J,358.3,16383,0)
 ;;=R31.21^^88^876^56
 ;;^UTILITY(U,$J,358.3,16383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16383,1,3,0)
 ;;=3^Hematuria,Microscopic,Asymptomatic
 ;;^UTILITY(U,$J,358.3,16383,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,16383,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,16384,0)
 ;;=R31.29^^88^876^57
 ;;^UTILITY(U,$J,358.3,16384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16384,1,3,0)
 ;;=3^Hematuria,Microscopic,Other
 ;;^UTILITY(U,$J,358.3,16384,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,16384,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,16385,0)
 ;;=R39.198^^88^876^70
 ;;^UTILITY(U,$J,358.3,16385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16385,1,3,0)
 ;;=3^Micturition,Oth Difficulties
 ;;^UTILITY(U,$J,358.3,16385,1,4,0)
 ;;=4^R39.198
 ;;^UTILITY(U,$J,358.3,16385,2)
 ;;=^5019347
 ;;^UTILITY(U,$J,358.3,16386,0)
 ;;=R39.191^^88^876^72
 ;;^UTILITY(U,$J,358.3,16386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16386,1,3,0)
 ;;=3^Need to Immediately Re-Void
 ;;^UTILITY(U,$J,358.3,16386,1,4,0)
 ;;=4^R39.191
 ;;^UTILITY(U,$J,358.3,16386,2)
 ;;=^5139199
 ;;^UTILITY(U,$J,358.3,16387,0)
 ;;=R39.192^^88^876^71
 ;;^UTILITY(U,$J,358.3,16387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16387,1,3,0)
 ;;=3^Micturition,Position Dependent
